A notable example of how VUS can affect clinical practice is underscored by the epithelial growth factor receptor gene (EGFR), a member of the receptor tyrosine kinase (RTK) family and known oncogene, common in non-small cell lung cancers (NSCLC) among others7–9. Here, EGFR is linked to non-small cell lung carcinoma.